ACTA1 and Hepatic fibrosis: As illustrated in Figs. 1 and 2, PGRN significantly attenuated CCl4-induced hepatic fibrosis with a concomitant reduction in α-SMA-, Col1a1-, and F4/80 antigen-positive cells.